Page last updated: 2024-12-07

eutypine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

eutypine: isolated from Eutypa lata; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID129326
CHEMBL ID501128
SCHEMBL ID272100
MeSH IDM0267680

Synonyms (11)

Synonym
C08448 ,
4-hydroxy-3-(3-methyl-3-butene-1-ynyl)benzaldehyde
eutypine
121007-17-8
CHEMBL501128 ,
AC1L2VEO ,
4-hydroxy-3-(3-methylbut-3-en-1-ynyl)benzaldehyde
SCHEMBL272100
DTXSID60153107
4-hydroxy-3-(3-methyl-3-butene-1-ynyl) benzaldehyde
benzaldehyde, 4-hydroxy-3-(3-methyl-3-buten-1-ynyl)-

Research Excerpts

Overview

Eutypine is a toxin produced by Eutypa lata, the causal agent of the dying-arm disease of grapevine.

ExcerptReferenceRelevance
"Eutypine is a toxin produced by Eutypa lata, the causal agent of the dying-arm disease of grapevine. "( Protonophoric activity of eutypine, a toxin from Eutypa lata, in plant mitochondria.
Davy de Virville, J; Deswarte, C; Eychenne, J; Fallot, J; Moreau, F; Roustan, JP, 1996
)
2.04
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID334213Phytotoxicity against grape leaf by leaf disk assay2003Journal of natural products, Feb, Volume: 66, Issue:2
Synthesis and structure-phytotoxicity relationships of acetylenic phenols and chromene metabolites, and their analogues, from the grapevine pathogen Eutypa lata.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's8 (80.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.42 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]